As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >


Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >


Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >


1 bis rue de l’Internationale – BP 60
91002 EVRY Cedex – FRANCE
Phone: +33 1 69 47 12 85

Laurence TIENNOT-HERMENT: President
Web Site >
Genethon Laboratory Genethon Laboratory

#Health / Well-being #Health / Well-being

  • Rare diseases
  • Biotherapies
  • Neuromuscular diseases
  • Gene therapy
  • Preclinical and clinical development

Field of Activity

Discovery, development and production of innovative therapies for rare genetic diseases, notably neuromuscular diseases.


Dedicated to the fight against rare diseases, Genethon has developed a unique expertise in the design and development of gene therapy products, from lab research to clinical trials. Its work work has led to several treatments on the market, in clinical trials, or at the R&D stage that are changing the lives of patients and their families.

With 200 scientists and professionals, Genethon pursues its mission: to develop treatments that change the lives of patients suffering from rare genetic diseases and to eradicate these diseases.

Genethon is a non-profit organization, created in 1990 by the French Association against Myopathies (AFM-Téléthon), thanks to donations from the first Telethons.

Description of the Products / Services / Technology

Genethon’s capabilities encompass all the expertise and skills involved in the discovery, preclinical, clinical and technological development, and biomanufacturing of gene therapy vectors:

Therapeutic Research departments:
design gene therapy approaches for several diseases.

Preclinical development, an in vitro and in vivo drug testing platform, which includes:

  • a vivarium hosting up to 4,000 rodents;
  • a functional investigation facility;
  • an imaging and cytometry platform, for molecular and physio-pathological investigation, from the single cell to the whole animal level;
  • a histology service.

Technological developments for gene therapy products:

  • bioprocess R&D;
  • identification and development of biological markers and theranostics
  • for monitoring neuromuscular diseases (Duchenne muscular dystrophy,in particular).

GMP biomanufacturing department:

  • GMP Production, Quality control and Assurance of clinical batches of drug candidates for gene therapy trials.
  • Clinical Development and Regulatory Affairs department: design, implementation and running of clinical trials.

DNA and cell bank:
national platform for the preparation and conservation of human biological samples.

  • Further information

    17 new patents filed in 2020

    22scientific publications in 2020.

    190 staff members (31/12/2020).

    10 Ongoing international gene therapy clinical trials and a portfolio of candidates at various preclinical stages.

Genopole’s Companies

#Health / Well-being

In same field

PEP-Therapy - Genopole's Company - logo 2021


PEP-Therapy develops innovative peptides as targeted therapies in oncology. The company operates a unique therapeutic technology based on cell penetrating & interfering peptides (CP&IP). These innovative molecules penetrate cells and specifically block relevant intracellular protein-protein interactions, thus inhibiting key pathological mechanisms.

Exosome Analytics - Entreprise génopolitaine

Exosome Analytics

Exosome Analytics develops techniques for EVs isolation and highly sensitive detection of protein markers on EVs for their application in liquid biopsy.



Platform for the bioproduction of RNA through fermentation in eukaryotic cells, a paradigm shift from in vitro synthesis

Kyron.Bio - Genopole's Company


Kyron.Bio is a biotech company using synthetic biology to produce new therapies with high yield, activity, and stability standards.

CGenetix - Entreprise génopolitaine


CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.

EndoGene.Bio - Genopole's Company


Research & development for an in vitro diagnostic tool for endometriosis

Exosome Analytics - Entreprise génopolitaine

Exosome Analytics

Exosome Analytics develops techniques for EVs isolation and highly sensitive detection of protein markers on EVs for their application in liquid biopsy.

Ciclix - StrokeHub - Genopole's company


Ciclix is a tech driven company specialized in process digitization for hospitals and focused on creating natural and efficient solutions for a variety of user profiles in the hospital environment.

Echoliv -Genopole's company


Echoliv is a MedTech startup that develops solutions based on artificial intelligence and applied to hepatic ultrasound. Our goal is to develop software to assist radiologists and hepatologists.

DeepTope - Genopole's company


– Characterization of antigen / antibody interactions (epitope / paratope) – Optimization of therapeutic antibodies

Theranovir - Genopole's Company


Biotechnology, R&D, Drug development, oncology, obesity, infectious diseases

Cell Environment - Genopole's company

Cell Environment

Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

Innovhem - Entreprise génopolitaine


Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

Whitelab Genomics - Genopole's Company

WhiteLab Genomics

Artificial intelligence to optimize and accelerate the development of gene therapies

Traaser - Genopole's Company


Software for biomedical data analysis

Synsight - Genopole's Company


Synsight is a company specializing in the discovery and preclinical development of new therapeutic molecules, based on a proprietary, integrated platform, combining artificial intelligence, molecular modeling and a functional experimental screening approach of High-Content Screening (HCS ).

Sebia - Genopole's Company


Design, manufacture and commercialization of in vitro diagnostic systems (instruments and reagents) for medical biology laboratories.

Santen - Genopole's Company


Santen SAS has developed its own sales force to commercialize ophthalmic products in France while Novagali Innovation Center is a center of excellence for Santen Group dedicated to research and development of innovative ophthalmic treatments for all segments of the eye.

Pharnext - Genopole's company

Pharnext SA

Pharnext develops new therapies and biomarkers based on network pharmacology with a proprietary discovery platform. The company is focused on pathologies with high unmet medical needs. These include neurodegenerative, orphan and common diseases (Charcot-Marie-Tooth disease Type 1A, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS)).

IntegraGen - Genopole's Company


IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

View all >
With the support from
Région île de France